Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
RxSight (RXST)
NASDAQ:RXST
Holding RXST?
Track your performance easily
Earnings Data
Report Date
Mar 11, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.17Last Year’s EPS
-0.26Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 10, 2021
|% Change Since: -40.85%
|Next Earnings Date:Sep 09, 2021
Earnings Call Sentiment|Positive
The earnings call reflects a positive trajectory for RxSight with strong revenue and sales growth, particularly in LAL and LDD units. The company has improved gross margins and revised its revenue guidance upwards. However, these positive developments are tempered by a net loss for the quarter and increased operating expenses. Additionally, external factors like hurricanes have had some impact on operations.Company Guidance
During the RxSight Q3 2024 earnings call, the company increased its full-year revenue guidance to approximately $140 million, marking a 57% year-over-year growth. The gross margin is expected to reach 70-71%, driven by a favorable product mix and reduced manufacturing costs. Operating expenses are projected at the lower end of the $135-136 million range, representing a 30-31% increase from the previous year. In Q3, RxSight reported revenues of $35.3 million, a 59% increase from the same period last year, with LAL sales generating $24.2 million and LDD sales contributing $10.1 million. The company highlighted its growing LDD installed base, now at 888 units, and a stable average selling price of approximately $130,000. The guidance reflects a strong Q4 revenue expectation of $40 million, with a similar gross margin and operating expenses at the low end of the $37-38 million range.Significant Revenue Growth
RxSight generated third quarter 2024 revenue of $35.3 million, up 59% compared to $22.2 million in the year-ago quarter and up 1% compared to $34.9 million in the second quarter of 2024.
LAL Revenue and Sales Increase
Sold 24,554 LALs generating $24.2 million in revenue, up 79% compared to the same quarter last year. LAL revenue represented 69% of total revenue.
Improved Gross Margin
Gross margin in the third quarter of 2024 was 71.4%, up from 61.9% in the year-ago quarter and 69.5% in the second quarter of 2024.
LDD Installed Base Growth
LDD installed base increased to 888 units, representing an increase of 51% compared to the year-ago period.
Full Year Guidance Revision
Full year 2024 revenue projected at $140 million, with a gross margin expected to be in the range of 70% to 71%.
---
RXST Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
RXST Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $50.85 | $48.01 | -5.59% |
| Aug 05, 2024 | $40.78 | $47.85 | +17.34% |
| May 06, 2024 | $62.84 | $62.19 | -1.03% |
| Feb 28, 2024 | $56.39 | $54.57 | -3.23% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does RxSight (RXST) report earnings?
RxSight (RXST) is schdueled to report earning on Mar 11, 2025, TBA Not Confirmed.
What is RxSight (RXST) earnings time?
RxSight (RXST) earnings time is at Mar 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RXST EPS forecast?
RXST EPS forecast for the fiscal quarter 2024 (Q4) is -0.17.
---